{"id":766803,"date":"2023-06-28T16:43:56","date_gmt":"2023-06-28T20:43:56","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/"},"modified":"2023-06-28T16:43:56","modified_gmt":"2023-06-28T20:43:56","slug":"cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/","title":{"rendered":"Cellectis S.A. Reports Results from Annual Shareholders\u2019 General Meeting Held on June 27, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, June  28, 2023  (GLOBE NEWSWIRE) &#8212; Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, hold its annual general meeting on June 27, 2023 at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4<sup>th<\/sup> floor, 75013 Paris, France.<\/p>\n<p align=\"justify\">At the meeting, during which more than 72% of shares were exercised, Resolutions 1 through 28 were adopted and resolution 29 was rejected, according to the management recommendations.<\/p>\n<p>The detailed results of the vote and the resolutions are available on the company\u2019s website:<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rKqzYVA_XDowMjrvQBqzjFDFioWxBwfuZhjj9OdesycEjlODcs3RsqyMODK4zmgyhs-EqEnloYEuDbMpkttDqiTNkMmBSRTDY7o8yrBPKeMzUQBZMfLazuSy1m-XrsufgEZrgc93GNsgAq7TUlQIUaXsKVJ24aioZdfamE2t3CBUhtkvAoM23_o_vTlYSsD2\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.cellectis.com\/en\/investors\/general-meetings\/<\/a><\/p>\n<p align=\"justify\">\n        <strong>About Cellectis\u00a0\u00a0<\/strong>\n      <\/p>\n<p align=\"justify\">Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. Cellectis utilizes an allogeneic approach for CAR-T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients, and a platform to make therapeutic gene editing in hemopoietic stem cells for various diseases. As a clinical-stage biopharmaceutical company with over 23 years of experience and expertise in gene editing, Cellectis is developing life-changing product candidates utilizing TALEN\u00ae, its gene editing technology, and PulseAgile, its pioneering electroporation system to harness the power of the immune system in order to treat diseases with unmet medical needs. Cellectis\u2019 headquarters are in Paris, France, with locations in New York, New York and Raleigh, North Carolina. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS).\u00a0\u00a0<\/p>\n<p align=\"justify\">For more information, visit our website <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HRzZPsNspd0UBm40412APayp8z8xIzE6Gfng2ENw3ocTtmpkc5p4dhfDgv6RA1nGmo_vknYFwDVlxRI7LVndo0czHks_oNmeaE5O7DmXzwI=\" rel=\"nofollow noopener\" target=\"_blank\">www.cellectis.com<\/a><br \/>Follow Cellectis on social media: @cellectis, LinkedIn and YouTube<\/p>\n<p align=\"justify\">For further information on Cellectis, please contact:\u00a0\u00a0\u00a0\u00a0<\/p>\n<p align=\"justify\">\n        <strong>Media contact:\u00a0\u00a0\u00a0\u00a0<\/strong>\n      <\/p>\n<p align=\"justify\">Pascalyne Wilson,\u00a0Director,\u00a0Communications,\u00a0+33 (0)7 76 99 14 33, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WDUXrlC12UwSmcLehHzepac9iiKNRtQMxL8bRPRBLBkyU4tg13SAuNtV5ZOELnKDZ_jt49OpgH6UkTFpUo0N1jysODWU5lmW8y_AmgbRsQQ=\" rel=\"nofollow noopener\" target=\"_blank\">media@cellectis.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Investor Relation contact:\u00a0\u00a0\u00a0\u00a0<\/strong>\n      <\/p>\n<p align=\"justify\">Arthur Stril, Chief Business Officer, +1 (347) 809 5980,\u00a0 <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=X3_a0ficilvjCGzDeqSo7EqIGguDlAS-IEpWvgaGLTr5ugL5BB54qA0ef7PaqyVNbNUj3RWkf7t5LQ4PevjojpV0757cE66UihTnxxAHq4s=\" rel=\"nofollow noopener\" target=\"_blank\">investors@cellectis.com<\/a><\/p>\n<p align=\"justify\">Ashley R. Robinson, LifeSci Advisors, +1 617\u00a0430 7577<\/p>\n<p id=\"gnw_attachments_section-header\">\n        <strong>Attachment<\/strong>\n      <\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n          <a href=\"https:\/\/ml.globenewswire.com\/Resource\/Download\/0ed31d3f-da80-4ae4-b61b-6370f8833a80\" rel=\"nofollow noopener\" target=\"_blank\">20230628_PR_voting results_ANG<\/a>\n        <\/li>\n<\/ul>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2NjM1MiM1NjY5NzU0IzIwNDk4Nzc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YzMzMmQzOTctZDBmZS00NTk0LWIyOGMtZTVlZTA1MDRlMWRmLTEwNjE0NDg=\/tiny\/Cellectis-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, June 28, 2023 (GLOBE NEWSWIRE) &#8212; Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, hold its annual general meeting on June 27, 2023 at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France. At the meeting, during which more than 72% of shares were exercised, Resolutions 1 through 28 were adopted and resolution 29 was rejected, according to the management recommendations. The detailed results of the vote and the resolutions are available on the company\u2019s website:https:\/\/www.cellectis.com\/en\/investors\/general-meetings\/ About Cellectis\u00a0\u00a0 Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. Cellectis utilizes &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cellectis S.A. Reports Results from Annual Shareholders\u2019 General Meeting Held on June 27, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-766803","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cellectis S.A. Reports Results from Annual Shareholders\u2019 General Meeting Held on June 27, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cellectis S.A. Reports Results from Annual Shareholders\u2019 General Meeting Held on June 27, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, June 28, 2023 (GLOBE NEWSWIRE) &#8212; Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, hold its annual general meeting on June 27, 2023 at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France. At the meeting, during which more than 72% of shares were exercised, Resolutions 1 through 28 were adopted and resolution 29 was rejected, according to the management recommendations. The detailed results of the vote and the resolutions are available on the company\u2019s website:https:\/\/www.cellectis.com\/en\/investors\/general-meetings\/ About Cellectis\u00a0\u00a0 Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. Cellectis utilizes &hellip; Continue reading &quot;Cellectis S.A. Reports Results from Annual Shareholders\u2019 General Meeting Held on June 27, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-28T20:43:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2NjM1MiM1NjY5NzU0IzIwNDk4Nzc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cellectis S.A. Reports Results from Annual Shareholders\u2019 General Meeting Held on June 27, 2023\",\"datePublished\":\"2023-06-28T20:43:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\\\/\"},\"wordCount\":306,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2NjM1MiM1NjY5NzU0IzIwNDk4Nzc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\\\/\",\"name\":\"Cellectis S.A. Reports Results from Annual Shareholders\u2019 General Meeting Held on June 27, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2NjM1MiM1NjY5NzU0IzIwNDk4Nzc=\",\"datePublished\":\"2023-06-28T20:43:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2NjM1MiM1NjY5NzU0IzIwNDk4Nzc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2NjM1MiM1NjY5NzU0IzIwNDk4Nzc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cellectis S.A. Reports Results from Annual Shareholders\u2019 General Meeting Held on June 27, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cellectis S.A. Reports Results from Annual Shareholders\u2019 General Meeting Held on June 27, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/","og_locale":"en_US","og_type":"article","og_title":"Cellectis S.A. Reports Results from Annual Shareholders\u2019 General Meeting Held on June 27, 2023 - Market Newsdesk","og_description":"NEW YORK, June 28, 2023 (GLOBE NEWSWIRE) &#8212; Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, hold its annual general meeting on June 27, 2023 at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France. At the meeting, during which more than 72% of shares were exercised, Resolutions 1 through 28 were adopted and resolution 29 was rejected, according to the management recommendations. The detailed results of the vote and the resolutions are available on the company\u2019s website:https:\/\/www.cellectis.com\/en\/investors\/general-meetings\/ About Cellectis\u00a0\u00a0 Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. Cellectis utilizes &hellip; Continue reading \"Cellectis S.A. Reports Results from Annual Shareholders\u2019 General Meeting Held on June 27, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-06-28T20:43:56+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2NjM1MiM1NjY5NzU0IzIwNDk4Nzc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cellectis S.A. Reports Results from Annual Shareholders\u2019 General Meeting Held on June 27, 2023","datePublished":"2023-06-28T20:43:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/"},"wordCount":306,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2NjM1MiM1NjY5NzU0IzIwNDk4Nzc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/","name":"Cellectis S.A. Reports Results from Annual Shareholders\u2019 General Meeting Held on June 27, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2NjM1MiM1NjY5NzU0IzIwNDk4Nzc=","datePublished":"2023-06-28T20:43:56+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2NjM1MiM1NjY5NzU0IzIwNDk4Nzc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2NjM1MiM1NjY5NzU0IzIwNDk4Nzc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cellectis S.A. Reports Results from Annual Shareholders\u2019 General Meeting Held on June 27, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/766803","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=766803"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/766803\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=766803"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=766803"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=766803"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}